Abstract
Heteroplasmic cells, harboring both mutant and normal mitochondrial DNAs (mtDNAs), must accumulate mutations to a threshold level before respiratory activity is affected. This phenomenon has led to the hypothesis of mtDNA complementation by inter-mitochondrial content mixing. The precise mechanisms of heteroplasmic complementation are unknown, but it depends both on the mtDNA nucleoid dynamics among mitochondria as well as the mitochondrial dynamics as influenced by mtDNA. We tracked nucleoids among the mitochondria in real time to show that they are shared after complete fusion but not ‘kiss-and-run’. Employing a cell hybrid model, we further show that mtDNA-less mitochondria, which have little ATP production and extensive Opa1 proteolytic cleavage, exhibit weak fusion activity among themselves, yet remain competent in fusing with healthy mitochondria in a mitofusin- and OPA1-dependent manner, resulting in restoration of metabolic function. Depletion of mtDNA by overexpression of the matrix-targeted nuclease UL12.5 resulted in heterogeneous mitochondrial membrane potential (ΔΨm) at the organelle level in mitofusin-null cells but not in wild type. In this system, overexpression of mitofusins or application of the fusion-promoting drug M1 could partially rescue the metabolic damage caused by UL12.5. Interestingly, mtDNA transcription/translation is not required for normal mitochondria to restore metabolic function to mtDNA-less mitochondria by fusion. Thus, interplay between mtDNA and fusion capacity governs a novel ‘initial metabolic complementation’.
Similar content being viewed by others
Abbreviations
- Cap:
-
Chloramphenicol
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- EB:
-
Ethidium bromide
- FBS:
-
Fetal bovine serum
- FI:
-
Fluorescence intensity
- IMM:
-
Inner mitochondrial membrane
- KFP:
-
Kindling fluorescent protein
- MEF:
-
Mouse embryonic fibroblast
- mt:
-
Mitochondrial
- mtFP:
-
Mitochondrial matrix-targeting fluorescent protein
- mtDNAs:
-
Mitochondrial DNAs
- OMM:
-
Outer mitochondrial membrane
- PAGFP:
-
Photoactivatable green fluorescent protein
- PBS:
-
Phosphate-buffered saline
- PEG:
-
Polyethylene glycol
- Q-PCR:
-
Quantitative polymerase chain reaction. Rho0 cells: cells lacking mtDNA
- Tfam:
-
Mitochondrial transcription factor A
- TMRM:
-
Tetramethylrhodamine methyl ester
- VK3:
-
Vitamin K3
- WT:
-
Wild type
- ΔΨm:
-
Mitochondrial membrane potential
References
Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482–1488
Greaves LC, Reeve AK, Taylor RW, Turnbull DM (2012) Mitochondrial DNA and disease. J Pathol 226:274–286. doi:10.1002/path.3028
Schapira AH (2012) Mitochondrial diseases. Lancet 379:1825–1834. doi:10.1016/S0140-6736(11)61305-6
Leonard JV, Schapira AH (2000) Mitochondrial respiratory chain disorders I: mitochondrial DNA defects. Lancet 355:299–304
Lightowlers RN, Chinnery PF, Turnbull DM, Howell N (1997) Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 13:450–455
Rossignol R, Faustin B, Rocher C, Malgat M, Mazat JP, Letellier T (2003) Mitochondrial threshold effects. Biochem J 370:751–762. doi:10.1042/BJ20021594
Chomyn A (1998) The myoclonic epilepsy and ragged-red fiber mutation provides new insights into human mitochondrial function and genetics. Am J Hum Genet 62:745–751. doi:10.1086/301813
Nakada K, Inoue K, Ono T, Isobe K, Ogura A, Goto YI, Nonaka I, Hayashi JI (2001) Inter-mitochondrial complementation: mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat Med 7:934–940. doi:10.1038/90976
Patterson GH, Lippincott-Schwartz J (2002) A photoactivatable GFP for selective photolabeling of proteins and cells. Science 297:1873–1877. doi:10.1126/science.1074952
Ando R, Hama H, Yamamoto-Hino M, Mizuno H, Miyawaki A (2002) An optical marker based on the UV-induced green-to-red photoconversion of a fluorescent protein. Proc Natl Acad Sci USA 99:12651–12656. doi:10.1073/pnas.202320599
Chudakov DM, Belousov VV, Zaraisky AG, Novoselov VV, Staroverov DB, Zorov DB, Lukyanov S, Lukyanov KA (2003) Kindling fluorescent proteins for precise in vivo photolabeling. Nat Biotechnol 21:191–194. doi:10.1038/nbt778
Liu X, Weaver D, Shirihai O, Hajnoczky G (2009) Mitochondrial ‘kiss-and-run’: interplay between mitochondrial motility and fusion-fission dynamics. EMBO J 28:3074–3089. doi:10.1038/emboj.2009.255
Chan DC (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125:1241–1252. doi:10.1016/j.cell.2006.06.010
McBride HM, Neuspiel M, Wasiak S (2006) Mitochondria: more than just a powerhouse. Curr Biol 16:R551–R560. doi:10.1016/j.cub.2006.06.054
Tatsuta T, Langer T (2008) Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J 27:306–314. doi:10.1038/sj.emboj.7601972
Liu X, Hajnoczky G (2011) Altered fusion dynamics underlie unique morphological changes in mitochondria during hypoxia-reoxygenation stress. Cell Death Differ 18:1561–1572. doi:10.1038/cdd.2011.13
Suen DF, Norris KL, Youle RJ (2008) Mitochondrial dynamics and apoptosis. Genes Dev 22:1577–1590. doi:10.1101/gad.1658508
Twig G, Liu X, Liesa M, Wikstrom JD, Molina AJ, Las G, Yaniv G, Hajnoczky G, Shirihai OS (2010) Biophysical properties of mitochondrial fusion events in pancreatic beta-cells and cardiac cells unravel potential control mechanisms of its selectivity. Am J Physiol Cell Physiol 299:C477–C487. doi:10.1152/ajpcell.00427.2009
Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27:433–446. doi:10.1038/sj.emboj.7601963
Legros F, Malka F, Frachon P, Lombes A, Rojo M (2004) Organization and dynamics of human mitochondrial DNA. J Cell Sci 117:2653–2662. doi:10.1242/jcs.01134
Chen H, Chomyn A, Chan DC (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280:26185–26192. doi:10.1074/jbc.M503062200
Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, Chan DC (2010) Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141:280–289. doi:10.1016/j.cell.2010.02.026
Nakada K, Sato A, Hayashi J (2009) Mitochondrial functional complementation in mitochondrial DNA-based diseases. Int J Biochem Cell Biol 41:1907–1913. doi:10.1016/j.biocel.2009.05.010
Enriquez JA, Cabezas-Herrera J, Bayona-Bafaluy MP, Attardi G (2000) Very rare complementation between mitochondria carrying different mitochondrial DNA mutations points to intrinsic genetic autonomy of the organelles in cultured human cells. J Biol Chem 275:11207–11215
Yoneda M, Miyatake T, Attardi G (1994) Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol Cell Biol 14:2699–2712
Ono T, Isobe K, Nakada K, Hayashi JI (2001) Human cells are protected from mitochondrial dysfunction by complementation of DNA products in fused mitochondria. Nat Genet 28:272–275. doi:10.1038/90116
Song Z, Ghochani M, McCaffery JM, Frey TG, Chan DC (2009) Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell 20:3525–3532. doi:10.1091/mbc.E09-03-0252
Tondera D, Grandemange S, Jourdain A, Karbowski M, Mattenberger Y, Herzig S, Da Cruz S, Clerc P, Raschke I, Merkwirth C, Ehses S, Krause F, Chan DC, Alexander C, Bauer C, Youle R, Langer T, Martinou JC (2009) SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J 28:1589–1600. doi:10.1038/emboj.2009.89
Legros F, Lombes A, Frachon P, Rojo M (2002) Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell 13:4343–4354. doi:10.1091/mbc.E02-06-0330
Baricault L, Segui B, Guegand L, Olichon A, Valette A, Larminat F, Lenaers G (2007) OPA1 cleavage depends on decreased mitochondrial ATP level and bivalent metals. Exp Cell Res 313:3800–3808. doi:10.1016/j.yexcr.2007.08.008
Ishihara N, Fujita Y, Oka T, Mihara K (2006) Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 25:2966–2977. doi:10.1038/sj.emboj.7601184
Duvezin-Caubet S, Jagasia R, Wagener J, Hofmann S, Trifunovic A, Hansson A, Chomyn A, Bauer MF, Attardi G, Larsson NG, Neupert W, Reichert AS (2006) Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 281:37972–37979. doi:10.1074/jbc.M606059200
Song Z, Chen H, Fiket M, Alexander C, Chan DC (2007) OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol 178:749–755. doi:10.1083/jcb.200704110
Delettre C, Griffoin JM, Kaplan J, Dollfus H, Lorenz B, Faivre L, Lenaers G, Belenguer P, Hamel CP (2001) Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet 109:584–591. doi:10.1007/s00439-001-0633-y
Gilkerson RW, Schon EA, Hernandez E, Davidson MM (2008) Mitochondrial nucleoids maintain genetic autonomy but allow for functional complementation. J Cell Biol 181:1117–1128. doi:10.1083/jcb.200712101
Corcoran JA, Saffran HA, Duguay BA, Smiley JR (2009) Herpes simplex virus UL12.5 targets mitochondria through a mitochondrial localization sequence proximal to the N terminus. J Virol 83:2601–2610. doi:10.1128/JVI.02087-08
Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119:873–887. doi:10.1016/j.cell.2004.11.003
Yi M, Weaver D, Hajnoczky G (2004) Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit. J Cell Biol 167:661–672. doi:10.1083/jcb.200406038
Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160:189–200. doi:10.1083/jcb.200211046
Santel A, Frank S, Gaume B, Herrler M, Youle RJ, Fuller MT (2003) Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 116:2763–2774. doi:10.1242/jcs.00479
Wang D, Wang J, Bonamy GM, Meeusen S, Brusch RG, Turk C, Yang P, Schultz PG (2012) A small molecule promotes mitochondrial fusion in mammalian cells. Angew Chem Int Ed Engl 51:9302–9305. doi:10.1002/anie.201204589
Jacobs HT, Lehtinen SK, Spelbrink JN (2000) No sex please, we’re mitochondria: a hypothesis on the somatic unit of inheritance of mammalian mtDNA. BioEssays 22:564–572. doi:10.1002/(SICI)1521-1878(200006)22:6<564:AID-BIES9>3.0.CO;2-4
D’Aurelio M, Gajewski CD, Lin MT, Mauck WM, Shao LZ, Lenaz G, Moraes CT, Manfredi G (2004) Heterologous mitochondrial DNA recombination in human cells. Hum Mol Genet 13:3171–3179. doi:10.1093/hmg/ddh326
Okamoto K, Perlman PS, Butow RA (1998) The sorting of mitochondrial DNA and mitochondrial proteins in zygotes: preferential transmission of mitochondrial DNA to the medial bud. J Cell Biol 142:613–623
He J, Cooper HM, Reyes A, Di Re M, Sembongi H, Litwin TR, Gao J, Neuman KC, Fearnley IM, Spinazzola A, Walker JE, Holt IJ (2012) Mitochondrial nucleoid interacting proteins support mitochondrial protein synthesis. Nucleic Acids Res 40:6109–6121. doi:10.1093/nar/gks266
Acknowledgments
We thank Hongwen Pang for his technical advice and Prof. György Hajnóczky, Prof. Xiaodong Shu, Dr. Juan Du, and Dr. Shen Chen for their expert views on the manuscript. This work was financially supported by the ‘Strategic Priority Research Program’ of the Chinese Academy of Sciences (XDA01020108), the Ministry of Science and Technology 973 program (2013CB967403 and 2012CB721105), the Ministry of Science and Technology 863 Program (2012AA02A708), the National Natural Science Foundation projects of China (31271527), International Cooperation Project of Guangdong Science and Technology Program (2012B050300022), Guangzhou Science and Technology Program (2014Y2-00161), Guangdong Natural Science Foundation for Distinguished Young Scientists (S20120011368), and the “One hundred Talents” Project for Prof. Xingguo Liu from the Chinese Academy of Sciences.
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Fig. S1 mtDNA nucleoids are shared after complete fusion but not ‘kiss-and-run’ in HeLa cells. a Tfam-DsRed co-localizes with anti-mtDNA fluorescence (Scale bar: 2 μm). b Quantitation of mtDNA nucleoid number after overexpressing Tfam-DsRed or mtDsRed in HeLa cells by Anti-DNA immunofluorescence (UT, Untreated). c Time course of mtDNA nucleoid movement during ‘kiss-and-run’ events after PAGFP photoactivation (Scale bar: 1 μm). The graph shows an increase of PAGFP FI in the acceptor mitochondrion (#1). d Time course of a typical mtDNA nucleoids sharing events in HeLa cells by mitochondrial complete fusion as determined by photoactivation (Scale bar: 1 μm). e The percentage of mtDNA nucleoid sharing events that occurred during ‘kiss-and-run’ events per 466.4 s imaging interval (n≥17). #, p < 0.01
Fig. S2 Acquisition of mtDNA nucleoids by mtDNA-less mitochondria by fusion events in Rho0 cells. a b The identification of Rho0 Hela cells. a The protein expression level of Tfam in WT and Rho cells. b Relative levels of Cox1 and Cox2 mtRNA in WT and Rho0 cells. c Time course of a typical mitochondrial fusion event in Rho0 cells (Scale bar: 1 μm). The graph shows an increase of PAGFP FI in the acceptor mitochondrion (#1). d e The heteroplasmic fusion between mtDNA-less and normal mitochondria by PEG-induced cell fusion. d Anti-DNA and anti-Tfam immunofluorescence of Rho0 and WT cells (Scale bar: 10 μm). e Anti-DNA and Anti-Tfam immunofluorescence of WT × Rho0 (mtDsRed) cell hybrids after PEG-mediated cell fusion for 7 h (Scale bar: 10 μm)
Fig. S3 OMM fusion frequency in Rho0 cells. a Labeling of a subpopulation of mitochondria by photoactivation of PAGFP in WT and Rho0 HeLa cells expressing both Omp25-PAGFP and mtDsRed (Scale bar: 10 μm). b OMM fusion was monitored by measuring the dilution of Omp25-PAGFP in subset for 200 s after photoactivation (n=5). c Comparison of OMM fusion events numbers in WT and Rho0 cells (n=5). #, p < 0.01
Fig. S4 Measurements of ΔΨm in WT and Rho0 HeLa cells and the generation of mouse Rho- cell lines by genetic approach. a Measurements of ΔΨm in WT and Rho0 by JC-1 staining (Scale bar: 10 μm). The ratio of red/green FI is used to measure ΔΨm. Rho0 cells had lower ratio, indicating lower ΔΨm than WT. b Measurements of ΔΨm in WT and Rho0 by TMRM staining (Scale bar: 10 μm). c Relative level of ND5 mtDNA in the days following infection with UL12.5-GFP. d Relative level of ND5 mtRNA in the days following infection with UL12.5-GFP. e Measurement of ΔΨm in MEF cells, Mfn1,2-/- MEF cells, and Opa1-/- MEF cells by TMRM staining (Scale bar: 10 μm)
Fig. S5 A single mtDNA-less mitochondrion gains a higher ΔΨm after fusing with a normal mitochondrion by ‘kiss-and-run’ (Scar bar 1 μm)
Fig. S6 Relative levels of Cox1/2 mtDNA in HeLa cells treated with 0.4 μg/mL EB for 48 h. #, p < 0.01
Fig. S7 Overexpression of Mfn1 or Mfn2 does affect neither mtDNA nor mtRNA levels. a Relative levels of ND2 and ND5 mtDNA in MEF cells after overexpression of Mfn1, Mfn2 or Mfn1/2 for 6 days. b Relative levels of ND2 and ND5 mtRNA in MEF cells after overexpression of Mfn1, Mfn2 or Mfn1/2 for 6 days
Rights and permissions
About this article
Cite this article
Yang, L., Long, Q., Liu, J. et al. Mitochondrial fusion provides an ‘initial metabolic complementation’ controlled by mtDNA. Cell. Mol. Life Sci. 72, 2585–2598 (2015). https://doi.org/10.1007/s00018-015-1863-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-015-1863-9